CLARITIN ALLERGY + SINUS EXTRA STRENGTH 10 MG
LORATADINE : 10 MG PSEUDOEPHEDRINE SULFATE : 240 MG · DIN 02260557 · BAYER INC
Health Canada status: MARKETED
What is CLARITIN ALLERGY + SINUS EXTRA STRENGTH?
CLARITIN ALLERGY + SINUS EXTRA STRENGTH 10 MG contains LORATADINE : 10 MG PSEUDOEPHEDRINE SULFATE : 240 MG. It is listed in the Health Canada Drug Product Database under DIN 02260557, held by BAYER INC, supplied as TABLET (IMMEDIATE AND EXTENDED RELEASE) for ORAL administration. Health Canada currently lists it as marketed, status dated 11-Sep-2015. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is CLARITIN ALLERGY + SINUS EXTRA STRENGTH used for?
CLARITIN ALLERGY + SINUS (loratadine 5 mg & pseudoephedrine sulfate 120 mg) modified-release tablets are indicated for the fast and long-lasting relief of nasal and ocular symptoms of upper respiratory mucosal congestion, such as in allergic rhinitis. CLARITIN® ALLERGY + SINUS EXTRA STRENGTH (loratadine 10 mg/pseudoephedrine sulfate 240 mg) modified-release tablets are indicated for the fast and long-lasting relief of symptoms associated with allergic rhinitis, including nasal congestion, sinus pressure and sinus congestion, sneezing, postnasal drip/discharge and tearing and redness of the eyes.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02260557 |
|---|---|
| Brand name | CLARITIN ALLERGY + SINUS EXTRA STRENGTH |
| Generic / active ingredient | LORATADINE : 10 MG PSEUDOEPHEDRINE SULFATE : 240 MG |
| Manufacturer | BAYER INC |
| Strength | 10 MG |
| Dosage form | TABLET (IMMEDIATE AND EXTENDED RELEASE) |
| Route of administration | ORAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | R01BA52 PSEUDOEPHEDRINE, COMBINATIONS |
| AHFS class | 12:12.12 ; 04:08.00 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 11-Sep-2015 |
| Original market date | 2005-03-01 00:00:00 |
How is it stored and handled?
null
How is it supplied?
CLARITIN® ALLERGY + SINUS is available in blister packages of 10’s, 20’s and 30’s. CLARITIN® ALLERGY + SINUS EXTRA STRENGTH is available in blister packages of 15’s.
What can be used instead?
Other Canadian products sharing ATC code R01BA52 PSEUDOEPHEDRINE, COMBINATIONS. 5 of 30 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| AERIUS SINUS + ALLERGY | 120 MG | TABLET (EXTENDED-RELEASE) | BAYER INC | MARKETED | DIN 02309300 |
| ALLEGRA-D | 60 MG | TABLET (IMMEDIATE AND EXTENDED RELEASE) | SANOFI CONSUMER HEALTH INC | MARKETED | DIN 02239853 |
| CLARITIN ALLERGY + SINUS | 5 MG | TABLET (IMMEDIATE AND EXTENDED RELEASE) | BAYER INC | MARKETED | DIN 01945157 |
| REACTINE COMPLETE | 120 MG | TABLET (EXTENDED-RELEASE) | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | MARKETED | DIN 02246162 |
| ACTIFED SYRUP | 1.25 MG / 5 ML | LIQUID | GLAXO WELLCOME INC. | CANCELLED POST MARKET | DIN 00068497 |
| ACTIFED TABLETS | 2.5 MG | TABLET | GLAXO WELLCOME INC. | CANCELLED POST MARKET | DIN 00068500 |
| ACTIFED TABLETS | 60 MG | TABLET | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | CANCELLED POST MARKET | DIN 02238302 |
| AERIUS DUAL ACTION 24 HOUR | 240 MG | TABLET (IMMEDIATE AND EXTENDED RELEASE) | BAYER INC | CANCELLED PRE MARKET | DIN 02377195 |
| BENADRYL DECONGESTANT TABLETS | 25 MG | TABLET | WARNER-LAMBERT CANADA INC. | CANCELLED POST MARKET | DIN 02019728 |
| BENYLIN D-AH FOR CHILDREN | 1 MG / 5 ML | SYRUP | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | CANCELLED PRE MARKET | DIN 02248334 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.